Rating History for Inozyme Pharma Inc. (INZY) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for INZY
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/19/2025 Allison M. Bratzel Downgrade Neutral
(Overweight)		 4.00
(N/A)		 1.42
(4.00)		 181.69% Details